Motif ID: Nfia
Z-value: 2.171
![logo of Nfia](../logos/Nfia.png)
Transcription factors associated with Nfia:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
Nfia | ENSMUSG00000028565.12 | Nfia |
Activity-expression correlation:
Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Nfia | mm10_v2_chr4_+_97772734_97772848 | -0.18 | 2.7e-01 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.6 | 5.6 | GO:1905072 | cardiac jelly development(GO:1905072) |
5.3 | 15.9 | GO:1902460 | transforming growth factor beta activation(GO:0036363) regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
3.5 | 17.6 | GO:0070327 | thyroid hormone transport(GO:0070327) |
3.2 | 3.2 | GO:0003134 | BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) |
3.0 | 11.9 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
2.9 | 8.6 | GO:0038095 | positive regulation of mast cell cytokine production(GO:0032765) Fc-epsilon receptor signaling pathway(GO:0038095) |
2.2 | 15.5 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
2.0 | 10.1 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
1.9 | 11.6 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
1.9 | 3.9 | GO:0072197 | ureter morphogenesis(GO:0072197) |
1.9 | 5.7 | GO:0006553 | lysine metabolic process(GO:0006553) |
1.8 | 5.4 | GO:0048687 | positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
1.7 | 8.6 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
1.7 | 5.0 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
1.6 | 7.9 | GO:1903609 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
1.5 | 4.5 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
1.4 | 4.3 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
1.4 | 4.2 | GO:0002030 | inhibitory G-protein coupled receptor phosphorylation(GO:0002030) |
1.4 | 4.2 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
1.4 | 9.7 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
1.3 | 2.6 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
1.3 | 5.2 | GO:0000255 | allantoin metabolic process(GO:0000255) |
1.3 | 9.0 | GO:0048251 | elastic fiber assembly(GO:0048251) |
1.3 | 5.1 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) cellular response to lipid hydroperoxide(GO:0071449) |
1.3 | 6.3 | GO:0060591 | chondroblast differentiation(GO:0060591) |
1.2 | 8.6 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
1.2 | 13.4 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
1.2 | 3.6 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
1.1 | 4.6 | GO:0002481 | antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) regulation of iron ion transport(GO:0034756) regulation of iron ion transmembrane transport(GO:0034759) |
1.1 | 4.5 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
1.1 | 2.2 | GO:1903984 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
1.1 | 3.3 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
1.1 | 1.1 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
1.0 | 3.1 | GO:0097350 | neutrophil clearance(GO:0097350) |
1.0 | 1.0 | GO:0003162 | atrioventricular node development(GO:0003162) |
1.0 | 2.9 | GO:1900747 | xanthine metabolic process(GO:0046110) negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
1.0 | 5.9 | GO:0032196 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) transposition(GO:0032196) |
1.0 | 4.8 | GO:0021905 | pancreatic A cell development(GO:0003322) forebrain-midbrain boundary formation(GO:0021905) somatic motor neuron fate commitment(GO:0021917) regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment(GO:0021918) sensory neuron migration(GO:1904937) |
0.9 | 2.8 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.9 | 3.7 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.9 | 0.9 | GO:0021593 | rhombomere morphogenesis(GO:0021593) |
0.9 | 1.9 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.9 | 5.5 | GO:0097473 | cellular response to light intensity(GO:0071484) cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
0.9 | 2.6 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.9 | 3.5 | GO:0090472 | dibasic protein processing(GO:0090472) |
0.9 | 1.7 | GO:0045168 | cell-cell signaling involved in cell fate commitment(GO:0045168) |
0.9 | 9.5 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.8 | 2.5 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
0.8 | 2.4 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.8 | 3.1 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.8 | 3.1 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.7 | 6.0 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.7 | 3.7 | GO:0090343 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) positive regulation of cell aging(GO:0090343) |
0.7 | 5.9 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.7 | 2.2 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) negative regulation of determination of dorsal identity(GO:2000016) |
0.7 | 3.6 | GO:0052428 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.7 | 2.2 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) |
0.7 | 2.1 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.7 | 2.1 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.7 | 3.5 | GO:1903181 | regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
0.7 | 2.8 | GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development(GO:0072272) |
0.7 | 11.7 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.6 | 12.2 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.6 | 2.5 | GO:1902724 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
0.6 | 3.7 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.6 | 1.2 | GO:2000282 | regulation of cellular amino acid biosynthetic process(GO:2000282) |
0.6 | 0.6 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
0.6 | 3.6 | GO:0032346 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
0.6 | 2.3 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.6 | 2.3 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.6 | 6.4 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.6 | 2.3 | GO:2000110 | protein sialylation(GO:1990743) negative regulation of macrophage apoptotic process(GO:2000110) |
0.6 | 5.6 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.5 | 1.1 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.5 | 0.5 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) |
0.5 | 2.1 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
0.5 | 1.6 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.5 | 1.0 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.5 | 2.1 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.5 | 2.6 | GO:0042891 | antibiotic transport(GO:0042891) dipeptide transport(GO:0042938) |
0.5 | 1.5 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.5 | 2.0 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
0.5 | 4.9 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.5 | 1.5 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.5 | 0.5 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
0.5 | 3.4 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.5 | 2.4 | GO:1902869 | regulation of amacrine cell differentiation(GO:1902869) |
0.5 | 2.4 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.5 | 1.4 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.5 | 2.4 | GO:0048539 | bone marrow development(GO:0048539) |
0.5 | 3.7 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.5 | 3.7 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.4 | 1.8 | GO:0099527 | postsynapse to nucleus signaling pathway(GO:0099527) |
0.4 | 1.3 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.4 | 1.3 | GO:0070428 | granuloma formation(GO:0002432) toll-like receptor 5 signaling pathway(GO:0034146) regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
0.4 | 0.9 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.4 | 1.7 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.4 | 1.3 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.4 | 4.2 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.4 | 0.4 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.4 | 1.2 | GO:1902524 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) positive regulation of protein K48-linked ubiquitination(GO:1902524) |
0.4 | 2.1 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.4 | 0.8 | GO:1903596 | regulation of gap junction assembly(GO:1903596) |
0.4 | 1.2 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.4 | 1.2 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.4 | 2.7 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.4 | 1.1 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.4 | 3.7 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.4 | 1.5 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.4 | 2.5 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.4 | 4.7 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.4 | 0.7 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.4 | 1.8 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
0.4 | 2.2 | GO:0098707 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.4 | 2.5 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
0.4 | 0.4 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.3 | 2.1 | GO:1902998 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
0.3 | 1.4 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
0.3 | 1.0 | GO:0006592 | ornithine biosynthetic process(GO:0006592) |
0.3 | 0.3 | GO:0032276 | regulation of gonadotropin secretion(GO:0032276) |
0.3 | 2.7 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.3 | 2.7 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.3 | 2.3 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.3 | 0.7 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.3 | 1.7 | GO:1905169 | protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) |
0.3 | 2.0 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.3 | 1.9 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.3 | 1.6 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.3 | 1.0 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.3 | 1.3 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.3 | 0.6 | GO:2000338 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
0.3 | 0.9 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
0.3 | 0.9 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.3 | 0.9 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.3 | 1.2 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.3 | 0.9 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.3 | 0.9 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.3 | 3.9 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.3 | 2.9 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.3 | 5.8 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.3 | 1.7 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.3 | 0.8 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.3 | 1.1 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
0.3 | 2.1 | GO:0000050 | urea cycle(GO:0000050) urea metabolic process(GO:0019627) |
0.3 | 1.3 | GO:1904721 | regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) negative regulation of immunoglobulin secretion(GO:0051025) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
0.3 | 5.7 | GO:0035036 | binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
0.3 | 1.0 | GO:0010756 | regulation of plasminogen activation(GO:0010755) positive regulation of plasminogen activation(GO:0010756) |
0.2 | 1.5 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.2 | 1.9 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.2 | 1.4 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.2 | 2.3 | GO:0002118 | aggressive behavior(GO:0002118) |
0.2 | 0.5 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.2 | 3.7 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.2 | 1.2 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.2 | 0.5 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.2 | 2.4 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.2 | 2.9 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.2 | 3.7 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.2 | 1.3 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.2 | 1.3 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 0.2 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.2 | 0.8 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.2 | 0.6 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.2 | 0.6 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
0.2 | 1.6 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.2 | 0.8 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.2 | 0.6 | GO:1903406 | regulation of sodium:potassium-exchanging ATPase activity(GO:1903406) |
0.2 | 0.8 | GO:1902512 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.2 | 1.0 | GO:2000427 | eosinophil chemotaxis(GO:0048245) positive regulation of apoptotic cell clearance(GO:2000427) |
0.2 | 0.8 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
0.2 | 0.4 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.2 | 0.4 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.2 | 0.6 | GO:0060596 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) mammary placode formation(GO:0060596) |
0.2 | 0.9 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.2 | 0.6 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
0.2 | 4.4 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.2 | 1.8 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) |
0.2 | 1.1 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.2 | 1.4 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
0.2 | 6.2 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.2 | 0.7 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.2 | 2.5 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.2 | 0.7 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.2 | 0.7 | GO:0021730 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.2 | 5.0 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
0.2 | 1.0 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.2 | 1.9 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.2 | 1.7 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.2 | 1.5 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.2 | 0.3 | GO:0021506 | anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
0.2 | 0.8 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.2 | 0.3 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.2 | 0.8 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.2 | 1.1 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.2 | 0.6 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.2 | 1.7 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.2 | 0.6 | GO:0018201 | peptidyl-glycine modification(GO:0018201) |
0.1 | 1.8 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.1 | 4.3 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 2.2 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 1.5 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.1 | 0.9 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.1 | 0.4 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.1 | 1.0 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.1 | 0.7 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 0.6 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.3 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
0.1 | 1.7 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 1.4 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.1 | 1.7 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.1 | 1.5 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.1 | 0.7 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 1.2 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.1 | 2.3 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 4.9 | GO:0060325 | face morphogenesis(GO:0060325) |
0.1 | 0.5 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.1 | 0.5 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.1 | 0.7 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 0.7 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.1 | 0.9 | GO:0046549 | phenol-containing compound catabolic process(GO:0019336) retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.1 | 0.1 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.1 | 3.7 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.1 | 0.3 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.9 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 1.5 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
0.1 | 0.9 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.1 | 4.0 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.1 | 2.0 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.1 | 4.3 | GO:0007520 | myoblast fusion(GO:0007520) |
0.1 | 1.0 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.1 | 0.5 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.1 | 2.8 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.4 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.1 | 0.8 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.1 | 9.7 | GO:0009408 | response to heat(GO:0009408) |
0.1 | 1.5 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 1.7 | GO:0097435 | fibril organization(GO:0097435) |
0.1 | 1.4 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.1 | 1.8 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.1 | GO:0060690 | epithelial cell differentiation involved in salivary gland development(GO:0060690) |
0.1 | 0.3 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 3.3 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.1 | 0.5 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.8 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.1 | 0.4 | GO:0015744 | succinate transport(GO:0015744) |
0.1 | 0.3 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.1 | 1.8 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.1 | 0.6 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.1 | 3.1 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.1 | 1.7 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 4.5 | GO:0006023 | aminoglycan biosynthetic process(GO:0006023) |
0.1 | 0.2 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.1 | 0.5 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 2.0 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.1 | 5.7 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.3 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
0.1 | 0.3 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.1 | 3.1 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 0.9 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.1 | 1.3 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 0.6 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.1 | 2.5 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.3 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.1 | 1.2 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.5 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 0.2 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.1 | 0.6 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 1.0 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.9 | GO:0046051 | UTP metabolic process(GO:0046051) |
0.1 | 0.4 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 0.5 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 1.0 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.1 | 0.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.2 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.1 | 0.9 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.1 | 1.0 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.3 | GO:0046709 | IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
0.1 | 0.8 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.1 | 0.3 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.1 | 0.4 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.1 | 1.1 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 0.3 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.1 | 0.5 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 1.9 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 2.9 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.1 | 0.5 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) follicle-stimulating hormone signaling pathway(GO:0042699) |
0.1 | 2.2 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 0.8 | GO:0090051 | regulation of skeletal muscle fiber development(GO:0048742) negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.1 | 1.0 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.1 | 0.8 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.9 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.1 | 1.2 | GO:0014904 | myotube cell development(GO:0014904) |
0.1 | 0.2 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.1 | 4.3 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.1 | 0.3 | GO:1903286 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.1 | 2.6 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.1 | 0.2 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
0.1 | 0.2 | GO:0036388 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) DNA replication preinitiation complex assembly(GO:0071163) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
0.1 | 0.1 | GO:0032242 | regulation of nucleoside transport(GO:0032242) regulation of neurotrophin production(GO:0032899) negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
0.1 | 0.4 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.1 | 0.2 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 0.3 | GO:0021780 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.1 | 0.7 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
0.1 | 0.3 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.1 | 1.7 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.1 | 0.5 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.1 | 0.3 | GO:0010796 | regulation of multivesicular body size(GO:0010796) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.1 | 0.7 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.1 | 0.5 | GO:0000022 | mitotic spindle elongation(GO:0000022) spindle midzone assembly(GO:0051255) mitotic spindle midzone assembly(GO:0051256) |
0.1 | 0.5 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.1 | 1.4 | GO:0006298 | mismatch repair(GO:0006298) |
0.1 | 0.3 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.1 | 0.7 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 1.3 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.6 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.3 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 0.2 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 0.6 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.1 | 1.0 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.1 | 0.3 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 0.2 | GO:1903624 | regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
0.1 | 0.5 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.1 | 1.5 | GO:0042255 | ribosome assembly(GO:0042255) |
0.1 | 0.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.3 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 1.0 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 0.6 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.4 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.1 | 0.1 | GO:0051593 | response to folic acid(GO:0051593) |
0.1 | 0.2 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 1.6 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
0.1 | 0.8 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 1.6 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.4 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.0 | 0.1 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.0 | 0.5 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.0 | 0.1 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.0 | 0.1 | GO:0002159 | desmosome assembly(GO:0002159) |
0.0 | 0.2 | GO:0000054 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.0 | 0.8 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.0 | 0.1 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.0 | 0.3 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 0.1 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.0 | 0.3 | GO:0014823 | response to activity(GO:0014823) |
0.0 | 0.9 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
0.0 | 3.3 | GO:0001889 | liver development(GO:0001889) |
0.0 | 0.4 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.0 | 0.9 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.9 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.0 | 0.1 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.0 | 0.1 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.0 | 1.0 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.0 | 0.3 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.0 | 5.0 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
0.0 | 1.8 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
0.0 | 1.0 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.6 | GO:0000338 | protein deneddylation(GO:0000338) |
0.0 | 0.2 | GO:1905146 | protein catabolic process in the vacuole(GO:0007039) lysosomal protein catabolic process(GO:1905146) |
0.0 | 0.1 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) mitochondrial RNA 3'-end processing(GO:0000965) |
0.0 | 1.2 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.0 | 3.0 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.3 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
0.0 | 0.2 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.2 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.0 | 0.3 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.0 | 1.4 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.0 | 0.4 | GO:0000423 | macromitophagy(GO:0000423) |
0.0 | 0.3 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.0 | 0.3 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.0 | 0.2 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.0 | 1.4 | GO:0070206 | protein trimerization(GO:0070206) |
0.0 | 0.1 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.0 | 0.3 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.0 | 0.8 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.6 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.1 | GO:0050912 | detection of chemical stimulus involved in sensory perception(GO:0050907) detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.0 | 0.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.0 | 0.6 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.0 | 1.0 | GO:0090102 | cochlea development(GO:0090102) |
0.0 | 0.5 | GO:0042993 | positive regulation of transcription factor import into nucleus(GO:0042993) |
0.0 | 0.3 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.0 | 0.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.0 | 0.3 | GO:0019430 | removal of superoxide radicals(GO:0019430) |
0.0 | 0.5 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.2 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 1.9 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.0 | 0.2 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.0 | 0.1 | GO:0007144 | female meiosis I(GO:0007144) |
0.0 | 1.7 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.0 | 0.3 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.0 | 0.6 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.0 | 0.1 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.0 | 0.4 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.1 | GO:0031214 | biomineral tissue development(GO:0031214) |
0.0 | 0.5 | GO:0046324 | regulation of glucose import(GO:0046324) |
0.0 | 0.8 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.2 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.0 | 0.1 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.0 | 0.1 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.0 | 0.5 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.3 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.3 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 0.6 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.8 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 1.3 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.2 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.0 | 0.9 | GO:0009060 | aerobic respiration(GO:0009060) |
0.0 | 0.2 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.0 | 0.6 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
0.0 | 0.2 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.0 | 0.1 | GO:0016128 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
0.0 | 0.0 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.0 | 0.4 | GO:0048286 | lung alveolus development(GO:0048286) |
0.0 | 0.0 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.7 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
0.0 | 0.5 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.0 | 0.1 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.0 | 0.1 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.0 | 0.0 | GO:0090282 | trophectodermal cellular morphogenesis(GO:0001831) positive regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071931) positive regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0090282) |
0.0 | 0.5 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.0 | 0.0 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.0 | 0.1 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.0 | 0.3 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
Gene overrepresentation in cellular_component category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 15.5 | GO:0097450 | astrocyte end-foot(GO:0097450) |
1.8 | 11.0 | GO:0035976 | AP1 complex(GO:0035976) |
1.8 | 5.4 | GO:0071953 | elastic fiber(GO:0071953) |
1.5 | 4.5 | GO:0005588 | collagen type V trimer(GO:0005588) |
1.1 | 2.1 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
1.0 | 4.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.9 | 11.1 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.9 | 3.6 | GO:0014802 | terminal cisterna(GO:0014802) |
0.9 | 4.3 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.8 | 2.5 | GO:0030934 | collagen type XII trimer(GO:0005595) anchoring collagen complex(GO:0030934) |
0.7 | 2.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.6 | 8.0 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.6 | 2.3 | GO:0032280 | symmetric synapse(GO:0032280) |
0.6 | 2.9 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.5 | 3.8 | GO:0005638 | lamin filament(GO:0005638) |
0.4 | 5.7 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.4 | 1.5 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.4 | 1.9 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.4 | 3.9 | GO:0031931 | TORC1 complex(GO:0031931) |
0.3 | 1.0 | GO:0044299 | C-fiber(GO:0044299) |
0.3 | 5.5 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.3 | 1.3 | GO:0032021 | NELF complex(GO:0032021) |
0.3 | 2.1 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.3 | 5.7 | GO:0005605 | basal lamina(GO:0005605) |
0.3 | 6.5 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.3 | 2.2 | GO:0097433 | dense body(GO:0097433) |
0.3 | 2.1 | GO:0033391 | chromatoid body(GO:0033391) |
0.3 | 9.1 | GO:0051233 | spindle midzone(GO:0051233) |
0.3 | 21.6 | GO:0072562 | blood microparticle(GO:0072562) |
0.3 | 1.0 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.2 | 2.7 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.2 | 1.7 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.2 | 3.8 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 2.3 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.2 | 1.8 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.2 | 3.5 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.2 | 1.1 | GO:0001652 | granular component(GO:0001652) |
0.2 | 2.3 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.2 | 0.8 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.2 | 1.0 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 3.1 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.2 | 1.8 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.2 | 1.0 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.2 | 0.6 | GO:0044753 | amphisome(GO:0044753) |
0.2 | 0.8 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.2 | 0.6 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.2 | 1.9 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 0.6 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
0.2 | 0.7 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.2 | 10.0 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 1.6 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.2 | 0.9 | GO:0014704 | intercalated disc(GO:0014704) |
0.2 | 0.3 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 1.0 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.2 | 6.8 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 0.9 | GO:0042588 | zymogen granule(GO:0042588) |
0.2 | 5.0 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 16.0 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 2.2 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 3.1 | GO:0043657 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 0.4 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.1 | 0.4 | GO:0005673 | transcription factor TFIIE complex(GO:0005673) |
0.1 | 1.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.7 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 6.3 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 2.0 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.1 | 1.0 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 4.4 | GO:0000786 | nucleosome(GO:0000786) |
0.1 | 37.5 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 0.7 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.1 | 0.9 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 1.9 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.8 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 1.7 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 6.5 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 0.9 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 2.5 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 3.4 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 0.8 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 0.5 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 4.5 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.1 | 0.7 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.1 | 0.3 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.1 | 0.5 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 1.1 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 0.3 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 0.9 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.5 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.9 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 2.9 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 5.0 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 0.7 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.1 | 1.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 1.0 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.2 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
0.1 | 9.8 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
0.1 | 5.1 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 7.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 1.9 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 3.1 | GO:0045177 | apical part of cell(GO:0045177) |
0.1 | 0.6 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 0.8 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 1.0 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 3.0 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 15.6 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.4 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 0.5 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 0.3 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 3.4 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 0.2 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.1 | 0.4 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 0.2 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 1.0 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 3.6 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.1 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.0 | 1.0 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 16.1 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 0.8 | GO:0030658 | transport vesicle membrane(GO:0030658) |
0.0 | 0.6 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 0.3 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 2.3 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 1.4 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.3 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 1.5 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.8 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) nuclear transcriptional repressor complex(GO:0090568) |
0.0 | 1.8 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 7.8 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 7.0 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 1.1 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.3 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 9.3 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 0.2 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.0 | 0.7 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 1.2 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.0 | 0.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.3 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.7 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.3 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 0.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.4 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.0 | 0.4 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.5 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.8 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 13.5 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.2 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.0 | 0.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.3 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.5 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.0 | 0.7 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 0.5 | GO:0012506 | vesicle membrane(GO:0012506) |
0.0 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.7 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 1.5 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 0.2 | GO:0031011 | Ino80 complex(GO:0031011) |
0.0 | 0.0 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.5 | GO:0005657 | replication fork(GO:0005657) |
0.0 | 0.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.4 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.0 | 5.1 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 0.5 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.7 | GO:0010008 | endosome membrane(GO:0010008) |
0.0 | 0.0 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.1 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.0 | 0.3 | GO:0090544 | BAF-type complex(GO:0090544) |
Gene overrepresentation in molecular_function category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.1 | 12.2 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
3.5 | 13.9 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
2.2 | 8.6 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
2.0 | 17.6 | GO:0070324 | thyroid hormone binding(GO:0070324) |
1.7 | 7.0 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
1.6 | 7.9 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
1.6 | 6.2 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
1.5 | 4.5 | GO:0004686 | elongation factor-2 kinase activity(GO:0004686) |
1.5 | 5.9 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
1.4 | 13.0 | GO:0036122 | BMP binding(GO:0036122) |
1.4 | 5.6 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.1 | 5.4 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.9 | 7.3 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.9 | 2.7 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.9 | 2.6 | GO:0042936 | dipeptide transporter activity(GO:0042936) |
0.8 | 5.0 | GO:0045545 | syndecan binding(GO:0045545) |
0.8 | 4.9 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.8 | 3.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.8 | 3.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.8 | 3.8 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.7 | 2.9 | GO:0043546 | molybdenum ion binding(GO:0030151) molybdopterin cofactor binding(GO:0043546) |
0.7 | 6.6 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.7 | 2.2 | GO:0098809 | nitrite reductase activity(GO:0098809) |
0.7 | 15.9 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.7 | 2.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.7 | 2.0 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.6 | 7.5 | GO:0050693 | LBD domain binding(GO:0050693) |
0.6 | 0.6 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.6 | 2.4 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.6 | 6.1 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.6 | 3.4 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.5 | 2.7 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.5 | 2.6 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.5 | 2.6 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.5 | 3.6 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.5 | 1.0 | GO:0070052 | collagen V binding(GO:0070052) |
0.5 | 11.1 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.5 | 6.6 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.5 | 6.5 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.5 | 7.4 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.5 | 1.5 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) hyaluronan synthase activity(GO:0050501) |
0.5 | 2.0 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.5 | 2.9 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.5 | 2.3 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.5 | 1.8 | GO:0038049 | glucocorticoid receptor activity(GO:0004883) transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.4 | 4.0 | GO:0032564 | dATP binding(GO:0032564) |
0.4 | 3.1 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.4 | 3.8 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.4 | 1.2 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
0.4 | 14.9 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.4 | 2.3 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) PH domain binding(GO:0042731) |
0.4 | 1.9 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.4 | 1.1 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.3 | 1.0 | GO:0017084 | glutamate 5-kinase activity(GO:0004349) glutamate-5-semialdehyde dehydrogenase activity(GO:0004350) delta1-pyrroline-5-carboxylate synthetase activity(GO:0017084) amino acid kinase activity(GO:0019202) |
0.3 | 1.0 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.3 | 2.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.3 | 3.0 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.3 | 2.9 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.3 | 2.9 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.3 | 2.5 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.3 | 1.3 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.3 | 1.6 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.3 | 3.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.3 | 2.2 | GO:0015091 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
0.3 | 4.8 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.3 | 0.6 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.3 | 3.8 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.3 | 0.9 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
0.3 | 0.9 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.3 | 2.0 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.3 | 3.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.3 | 2.5 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.3 | 2.2 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.3 | 1.6 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.3 | 5.0 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.3 | 1.8 | GO:0015288 | porin activity(GO:0015288) |
0.3 | 1.3 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.3 | 2.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.3 | 2.8 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 1.0 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.2 | 1.0 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.2 | 1.9 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 2.4 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.2 | 5.1 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.2 | 3.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 0.9 | GO:0051425 | PTB domain binding(GO:0051425) |
0.2 | 5.5 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.2 | 7.2 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.2 | 1.3 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.2 | 4.3 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.2 | 0.9 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.2 | 2.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 2.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.2 | 0.4 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.2 | 1.2 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.2 | 1.6 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.2 | 0.8 | GO:0070573 | tripeptidyl-peptidase activity(GO:0008240) metallodipeptidase activity(GO:0070573) |
0.2 | 0.6 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.2 | 0.8 | GO:0033883 | pyridoxal phosphatase activity(GO:0033883) |
0.2 | 1.2 | GO:0009374 | biotin binding(GO:0009374) |
0.2 | 7.0 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.2 | 7.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.2 | 6.7 | GO:0042805 | actinin binding(GO:0042805) |
0.2 | 1.0 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.2 | 2.1 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 2.6 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.2 | 1.3 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.2 | 0.2 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.2 | 0.7 | GO:2001069 | glycogen binding(GO:2001069) |
0.2 | 1.1 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 0.4 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.2 | 1.4 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.2 | 0.7 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.2 | 16.7 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 1.8 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.2 | 5.6 | GO:0019838 | growth factor binding(GO:0019838) |
0.2 | 5.0 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 2.4 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.2 | 0.3 | GO:0019002 | GMP binding(GO:0019002) |
0.2 | 1.0 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.2 | 1.4 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.2 | 1.8 | GO:0030957 | Tat protein binding(GO:0030957) |
0.2 | 0.8 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.2 | 1.7 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.2 | 1.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 2.1 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.2 | 2.1 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 0.5 | GO:0031896 | alpha-1A adrenergic receptor binding(GO:0031691) alpha-1B adrenergic receptor binding(GO:0031692) follicle-stimulating hormone receptor binding(GO:0031762) V2 vasopressin receptor binding(GO:0031896) |
0.2 | 0.6 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
0.2 | 0.5 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.2 | 1.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.2 | 3.4 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.2 | 0.6 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.2 | 1.7 | GO:0044548 | S100 protein binding(GO:0044548) |
0.2 | 0.9 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 9.9 | GO:0019003 | GDP binding(GO:0019003) |
0.2 | 0.6 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.2 | 4.4 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 0.4 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
0.1 | 1.6 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 0.8 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.1 | 3.7 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 0.5 | GO:0086038 | calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086038) |
0.1 | 0.8 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 1.3 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 2.1 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 1.2 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.1 | 5.7 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 2.5 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.5 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 0.3 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 1.0 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.8 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) RNA polymerase II transcription corepressor binding(GO:0001226) |
0.1 | 0.9 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.1 | 0.9 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 1.9 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.7 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.1 | 2.8 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 0.3 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.1 | 1.4 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 4.6 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 2.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.3 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.1 | 0.3 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.1 | 0.5 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 0.6 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 1.6 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.4 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
0.1 | 0.5 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.1 | 0.1 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 5.8 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 0.3 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.1 | 0.4 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.1 | 1.0 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.6 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 0.6 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 1.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.5 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.4 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.4 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 0.2 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 5.1 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 3.2 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 0.3 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.1 | 0.8 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 1.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 1.2 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 1.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.5 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.1 | 0.3 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.1 | 0.2 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.1 | 0.4 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.1 | 0.8 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.1 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.1 | 1.0 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 1.1 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.4 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.3 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 8.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.5 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.1 | 0.8 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.4 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 0.4 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.0 | 0.6 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 1.1 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.3 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 4.6 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.0 | 0.3 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.6 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.1 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.0 | 0.6 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.1 | GO:0035605 | peptidyl-cysteine S-nitrosylase activity(GO:0035605) |
0.0 | 0.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 1.3 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.4 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 2.0 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.0 | 0.7 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 1.6 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 0.1 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 1.1 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.1 | GO:0004104 | cholinesterase activity(GO:0004104) choline binding(GO:0033265) |
0.0 | 1.7 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.3 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 1.9 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.7 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.0 | 0.0 | GO:0015925 | galactosidase activity(GO:0015925) |
0.0 | 2.0 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 0.6 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.4 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.2 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.0 | 0.8 | GO:0004407 | histone deacetylase activity(GO:0004407) protein deacetylase activity(GO:0033558) |
0.0 | 0.7 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.1 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.0 | 0.6 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 1.0 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.5 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 0.3 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.2 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.5 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.7 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.0 | 0.1 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.4 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.0 | 0.4 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 0.5 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.2 | GO:0015149 | glucose transmembrane transporter activity(GO:0005355) hexose transmembrane transporter activity(GO:0015149) |
0.0 | 0.7 | GO:0048029 | monosaccharide binding(GO:0048029) |
0.0 | 0.5 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 0.5 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.9 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.7 | GO:0016209 | antioxidant activity(GO:0016209) |
0.0 | 0.3 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.0 | 0.4 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.3 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.0 | 0.0 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.0 | 0.1 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.0 | 0.9 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.0 | 0.3 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.0 | 0.3 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 0.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.2 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.0 | 0.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.7 | GO:0019209 | kinase activator activity(GO:0019209) |
0.0 | 0.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.4 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 0.2 | GO:0070034 | telomerase RNA binding(GO:0070034) |
Gene overrepresentation in C2:CP category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 12.1 | PID_TCR_RAS_PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.6 | 16.6 | PID_INTEGRIN_A9B1_PATHWAY | Alpha9 beta1 integrin signaling events |
0.5 | 8.8 | ST_STAT3_PATHWAY | STAT3 Pathway |
0.4 | 3.3 | PID_ATF2_PATHWAY | ATF-2 transcription factor network |
0.4 | 17.7 | SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.4 | 10.9 | PID_VEGFR1_PATHWAY | VEGFR1 specific signals |
0.4 | 2.6 | ST_PAC1_RECEPTOR_PATHWAY | PAC1 Receptor Pathway |
0.4 | 2.8 | PID_VEGF_VEGFR_PATHWAY | VEGF and VEGFR signaling network |
0.3 | 16.2 | PID_HNF3B_PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.3 | 5.3 | NABA_BASEMENT_MEMBRANES | Genes encoding structural components of basement membranes |
0.3 | 7.3 | PID_SHP2_PATHWAY | SHP2 signaling |
0.3 | 40.0 | NABA_ECM_GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.3 | 7.8 | NABA_COLLAGENS | Genes encoding collagen proteins |
0.2 | 4.7 | PID_P38_GAMMA_DELTA_PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.2 | 3.5 | SA_G1_AND_S_PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.2 | 15.6 | PID_HIF1_TFPATHWAY | HIF-1-alpha transcription factor network |
0.2 | 4.3 | PID_S1P_META_PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.2 | 9.1 | PID_CD8_TCR_PATHWAY | TCR signaling in naïve CD8+ T cells |
0.2 | 2.0 | PID_ALPHA_SYNUCLEIN_PATHWAY | Alpha-synuclein signaling |
0.2 | 1.4 | PID_PDGFRA_PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 3.5 | PID_HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 2.6 | PID_IL2_1PATHWAY | IL2-mediated signaling events |
0.2 | 0.8 | SA_MMP_CYTOKINE_CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 1.8 | PID_GLYPICAN_1PATHWAY | Glypican 1 network |
0.1 | 1.0 | PID_S1P_S1P2_PATHWAY | S1P2 pathway |
0.1 | 2.3 | PID_EPHA_FWDPATHWAY | EPHA forward signaling |
0.1 | 15.9 | NABA_ECM_REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.8 | SA_G2_AND_M_PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 3.9 | NABA_CORE_MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.1 | 3.0 | PID_NETRIN_PATHWAY | Netrin-mediated signaling events |
0.1 | 21.1 | NABA_SECRETED_FACTORS | Genes encoding secreted soluble factors |
0.1 | 2.4 | PID_HDAC_CLASSIII_PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 2.9 | PID_FGF_PATHWAY | FGF signaling pathway |
0.1 | 2.1 | ST_TUMOR_NECROSIS_FACTOR_PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 4.5 | PID_AP1_PATHWAY | AP-1 transcription factor network |
0.1 | 3.2 | PID_FAK_PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 6.4 | PID_NOTCH_PATHWAY | Notch signaling pathway |
0.1 | 0.6 | PID_HIF1A_PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 1.9 | PID_HES_HEY_PATHWAY | Notch-mediated HES/HEY network |
0.1 | 4.4 | PID_CASPASE_PATHWAY | Caspase cascade in apoptosis |
0.1 | 3.8 | ST_FAS_SIGNALING_PATHWAY | Fas Signaling Pathway |
0.1 | 4.7 | PID_MTOR_4PATHWAY | mTOR signaling pathway |
0.1 | 2.1 | PID_INSULIN_PATHWAY | Insulin Pathway |
0.1 | 0.9 | ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 1.5 | PID_DELTA_NP63_PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 1.6 | PID_TRKR_PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 1.2 | PID_DNA_PK_PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.4 | ST_INTEGRIN_SIGNALING_PATHWAY | Integrin Signaling Pathway |
0.0 | 0.7 | PID_HNF3A_PATHWAY | FOXA1 transcription factor network |
0.0 | 0.8 | PID_TCR_CALCIUM_PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.1 | PID_ERBB_NETWORK_PATHWAY | ErbB receptor signaling network |
0.0 | 0.6 | PID_TOLL_ENDOGENOUS_PATHWAY | Endogenous TLR signaling |
0.0 | 0.5 | PID_CXCR3_PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.8 | PID_ARF_3PATHWAY | Arf1 pathway |
0.0 | 0.2 | PID_CERAMIDE_PATHWAY | Ceramide signaling pathway |
0.0 | 0.8 | PID_MET_PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.9 | PID_RXR_VDR_PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.6 | PID_BARD1_PATHWAY | BARD1 signaling events |
0.0 | 0.6 | PID_ATM_PATHWAY | ATM pathway |
0.0 | 0.4 | PID_VEGFR1_2_PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.5 | PID_IL2_STAT5_PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.5 | PID_TAP63_PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 1.5 | PID_HDAC_CLASSI_PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.7 | PID_TGFBR_PATHWAY | TGF-beta receptor signaling |
0.0 | 0.1 | PID_ECADHERIN_KERATINOCYTE_PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.2 | PID_ERBB2_ERBB3_PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.5 | PID_MYC_REPRESS_PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.8 | PID_P73PATHWAY | p73 transcription factor network |
0.0 | 0.1 | PID_PTP1B_PATHWAY | Signaling events mediated by PTP1B |
Gene overrepresentation in C2:CP:REACTOME category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 4.6 | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
1.1 | 1.1 | REACTOME_SIGNALING_BY_NOTCH2 | Genes involved in Signaling by NOTCH2 |
1.0 | 7.6 | REACTOME_TRANSPORT_OF_ORGANIC_ANIONS | Genes involved in Transport of organic anions |
0.9 | 6.6 | REACTOME_SIGNALING_BY_NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.6 | 11.2 | REACTOME_ACTIVATION_OF_THE_AP1_FAMILY_OF_TRANSCRIPTION_FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.6 | 23.9 | REACTOME_NUCLEAR_SIGNALING_BY_ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.5 | 13.3 | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS | Genes involved in Regulation of gene expression in beta cells |
0.4 | 4.4 | REACTOME_INTRINSIC_PATHWAY | Genes involved in Intrinsic Pathway |
0.4 | 3.5 | REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.4 | 2.2 | REACTOME_SIGNALING_BY_EGFR_IN_CANCER | Genes involved in Signaling by EGFR in Cancer |
0.4 | 6.8 | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.4 | 9.6 | REACTOME_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.4 | 2.3 | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.4 | 5.9 | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.4 | 20.0 | REACTOME_AMYLOIDS | Genes involved in Amyloids |
0.3 | 6.9 | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.3 | 3.6 | REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.3 | 2.4 | REACTOME_THE_ACTIVATION_OF_ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.3 | 4.6 | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.3 | 3.6 | REACTOME_CS_DS_DEGRADATION | Genes involved in CS/DS degradation |
0.3 | 5.1 | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | Genes involved in Growth hormone receptor signaling |
0.3 | 2.6 | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.3 | 6.1 | REACTOME_ACTIVATION_OF_GENES_BY_ATF4 | Genes involved in Activation of Genes by ATF4 |
0.2 | 0.5 | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.2 | 4.7 | REACTOME_GLUTATHIONE_CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 2.4 | REACTOME_PURINE_CATABOLISM | Genes involved in Purine catabolism |
0.2 | 2.2 | REACTOME_REMOVAL_OF_THE_FLAP_INTERMEDIATE_FROM_THE_C_STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.2 | 2.3 | REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 11.4 | REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.2 | 5.2 | REACTOME_SULFUR_AMINO_ACID_METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 1.5 | REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 5.6 | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.2 | 3.3 | REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 11.3 | REACTOME_COLLAGEN_FORMATION | Genes involved in Collagen formation |
0.2 | 1.1 | REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 2.8 | REACTOME_MTORC1_MEDIATED_SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.2 | 3.5 | REACTOME_OXYGEN_DEPENDENT_PROLINE_HYDROXYLATION_OF_HYPOXIA_INDUCIBLE_FACTOR_ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 4.1 | REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.2 | 1.0 | REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 4.7 | REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 4.9 | REACTOME_GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 2.0 | REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 1.5 | REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 1.8 | REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 6.7 | REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 0.4 | REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 1.5 | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 3.4 | REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 3.5 | REACTOME_LYSOSOME_VESICLE_BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 1.3 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 5.1 | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 0.9 | REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 1.4 | REACTOME_TIE2_SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 0.8 | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 0.9 | REACTOME_AMINE_DERIVED_HORMONES | Genes involved in Amine-derived hormones |
0.1 | 2.2 | REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 0.5 | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 0.8 | REACTOME_HDL_MEDIATED_LIPID_TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 0.9 | REACTOME_BASE_FREE_SUGAR_PHOSPHATE_REMOVAL_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 0.6 | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 3.9 | REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 5.1 | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 0.5 | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 1.2 | REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 1.0 | REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 1.4 | REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 0.7 | REACTOME_GAP_JUNCTION_DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 2.7 | REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 2.0 | REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINE_NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 1.3 | REACTOME_SYNTHESIS_OF_PC | Genes involved in Synthesis of PC |
0.1 | 1.0 | REACTOME_DEADENYLATION_OF_MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 1.2 | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.7 | REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 3.1 | REACTOME_PEPTIDE_CHAIN_ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 1.5 | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 3.5 | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 1.0 | REACTOME_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 0.4 | REACTOME_FACILITATIVE_NA_INDEPENDENT_GLUCOSE_TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 2.1 | REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_ | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.8 | REACTOME_METABOLISM_OF_PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.8 | REACTOME_KERATAN_SULFATE_BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 1.2 | REACTOME_SYNTHESIS_OF_PA | Genes involved in Synthesis of PA |
0.0 | 1.3 | REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.7 | REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 1.9 | REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.1 | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.6 | REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.8 | REACTOME_EGFR_DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.3 | REACTOME_BASIGIN_INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.7 | REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE | Genes involved in Regulation of mitotic cell cycle |
0.0 | 0.3 | REACTOME_ROLE_OF_DCC_IN_REGULATING_APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 1.5 | REACTOME_RESPIRATORY_ELECTRON_TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.3 | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.8 | REACTOME_RNA_POL_III_TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.0 | 0.6 | REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.2 | REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.0 | 0.3 | REACTOME_MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.3 | REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.2 | REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 0.3 | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.2 | REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |